glp 1 during perimenopause GLP-1 Medications and Their Role In Menopause Weight Gain GLP-1 and Perimenopause: Clinical Evidence

doi: 10.1038/s41467-024-49655-6

GLP-1 + GIP treatments should not be used by individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

A proposal of ovarian ERAANPS (endothelin-renin-angiotensin-atrial natriuretic peptide system) and effects of tokishakuyakusan, keishibukuryogan, shakuyakukanzoto and unkeito on the ERAANPS

Arentz S, Smith CA, Abbott J, Bensoussan A

Nausea and diarrhea were common gastrointestinal side effects that occasionally caused people to stop taking the medication

Committed to exceptional service and meaningful community impact, Nutrishop empowers customers to live stronger, healthier lives while giving entrepreneurs the tools and ongoing support to build successful, purpose-driven businesses